Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized double-blind dose-finding study of tininurad tablets versus febuxostat in hyperuricemia with or without gout
CTR20251381Phase 2Completed
- Sponsor
- Tianjin Institute of Pharmaceutical Research
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tininurad in hyperuricemia, gout, sponsored by Tianjin Institute of Pharmaceutical Research. Started Apr 2025; status: completed.
02
Drugs
tininurad
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on CTR20251381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251381.